Amgen

Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year
BioSpace
Thu, 10/31/24 - 09:42 am
Amgen
obesity
MariTide
Regeneron loses bid to block Amgen's Eylea biosimilar launch in US
Reuters
Tue, 10/22/24 - 11:30 pm
Regeneron
Amgen
biosimilars
Eylea
FDA Pushes Back PDUFA Dates for Amgen and Intercept
BioSpace
Fri, 10/18/24 - 11:28 am
FDA
Amgen
Lumakras
colorectal cancer
Intercept Pharma
Ocaliva
primary biliary cholangitis
Drugmakers are racing to find the next Wegovy. These obesity trials are ones to watch.
BioPharma Dive
Fri, 10/11/24 - 11:10 am
Novo Nordisk
Eli Lilly
obesity
Zebound
Wegovy
CagriSema
Amgen
MariTide
oforglipron
Veru
enobosarm
nimacimab
Skye Bioscience
Amgen must face lawsuit claiming it hid $10.7 billion tax bill
Reuters
Tue, 10/1/24 - 10:22 pm
Amgen
legal
IRS
taxes
Amgen, Family Heart Foundation launch at-home cholesterol screening for LDL-C Awareness Day
Medical Marketing and Media
Mon, 09/30/24 - 08:47 pm
Amgen
Cholesterol Connect
LDL-C
diagnostics
cholesterol
Amgen claims success for two immune drugs, but results underwhelm Wall Street
BioPharma Dive
Wed, 09/25/24 - 11:46 am
Amgen
rocatinlimab
atopic dermatitis
Uplizna
myasthenia gravis
Amgen's muscular disorder drug meets main goal in late-stage study
Reuters
Tue, 09/24/24 - 09:59 pm
Amgen
Uplinza
clinical trials
myasthenia gravis
Regeneron's stock drops as it loses bid to block Amgen's Eylea biosimilar
Fierce Pharma
Tue, 09/24/24 - 11:56 am
Regeneron
Amgen
legal
biosimilars
Eylea
Where Will Amgen Be in 5 Years?
Motley Fool
Fri, 09/20/24 - 10:14 am
Amgen
Weight-loss market to see 16 new drugs by 2029, report estimates
Reuters
Tue, 09/10/24 - 04:29 pm
weight loss
obesity
Amgen
Pfizer
Roche
Novo Nordisk
Eli Lilly
Boehinger Ingelheim
Structure Therapeutics
Viking Therapeutics
Zealand Pharma
Altimmune
Viridian says thyroid eye disease drug effective in reducing symptoms
Reuters
Tue, 09/10/24 - 09:47 am
Viridian Therapeutics
thyroid eye disease
clinical trials
veligrotug
Tepezza
Amgen
Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases
BioSpace
Thu, 09/5/24 - 11:40 am
Amgen
obesity
MariTide
Medicare
Roche tops pharma rivals for reputation among rare disease patient groups
Medical Marketing and Media
Wed, 08/21/24 - 11:39 am
Roche
reputation
Rare Diseases
Biomarin
Amgen
BioMarin creates new-look R&D and deal teams with Roche’s Sabry, Amgen’s Friberg
Fierce Biotech
Wed, 08/21/24 - 11:31 am
Biomarin
R&D
Roche
Amgen
IRA negotiations slash Medicare prices for Big Pharma blockbusters by up to 79%
Fierce Pharma
Thu, 08/15/24 - 11:55 am
Medicare
drug pricing
Inflation Reduction Act
JNJ
Xarelto
Imbruvica
Stelara
Bristol Myers Squibb
Eliquis
Eli Lilly
Jardiance
Merck
Januvia
Amgen
Enbrel
AstraZeneca
Farxiga
Novo Nordisk
Fiasp
Novartis
Entresto
Amgen sues Samsung biotech unit over bone drug copies
Reuters
Tue, 08/13/24 - 11:08 pm
Amgen
Samsung
biologics
biosimilars
legal
Prolia
Xgeva
5 Obesity Readouts to Watch in the Second Half of 2024
BioSpace
Tue, 08/13/24 - 11:47 am
obesity
clinical trials
Novo Nordisk
CagriSema
Amgen
MariTide
Monlunabant
Aphaia Pharma
APHD-012
Terns Pharmaceuticals
TERN-601
Biotech giant Amgen announces new office in tech-savvy Hyderabad
Investment Monitor
Sun, 08/11/24 - 10:39 pm
Amgen
India
Hyderabad
Pharma execs react to final drug price negotiations with Medicare
Pharma Voice
Fri, 08/9/24 - 11:21 am
Medicare
drug pricing
Inflation Reduction Act
Bristol Myers Squibb
Eli Lilly
JNJ
Bayer
Merck
AstraZeneca
Novartis
Amgen
AbbVie
Novo Nordisk

Pages